Access DX, former CEO and businessman settle for $36.4 million in FCA case

The U.S. said the defendants paid kickbacks, billed Medicare and Medicaid for medically unnecessary genetic testing, and used false telemedicine orders; a whistleblower will receive $7.2 million.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.